发明名称 Detection of cyp1a1, cyp3a4, cyp2d6 and nat2 variants and therapeutic uses thereof
摘要 The present invention relates to a method of detecting genetic variation in individuals by PCR amplification of the locus of interest, transferring the resulting PCR products to a membrane filter, hybridizing with allele-specific-oligonucleotides (ASOs), and visualizing the results. Such a method is in the field of diagnostics, pharmacogenetics, cancer therapeutics, and drug metabolism. In particular, the present invention relates to the detection of genetic polymorphisms in gene encoding xenobiotics metabolizing enzymes CYP1A1, CYP2D6, CYP3A4, and NAT2.
申请公布号 AU6322299(A) 申请公布日期 2000.05.15
申请号 AU19990063222 申请日期 1999.10.22
申请人 HOPITAL SAINTE-JUSTINE 发明人 DANIEL SINNETT;DAMIAN LABUDA
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址